A Trial for Patients With Gestational Trophoblastic Disease

Clinical trial NCT00190918 · COMPLETED

Trial details

NCT number: NCT00190918
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Trophoblastic Neoplasms Uterine Neoplasms Hydatidiform Mole Choriocarcinoma

Start date: 2006-07-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.